Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome?

Thomas J P Mangnus Krishna D Bharwani Willem A Dik Sara J Baart Maaike Dirckx Frank J P M Huygen

Published in: Pain medicine (Malden, Mass.) (2023)

: Our findings suggest that serum sIL-2R levels cannot be used as a biomarker for syndrome severity in persistent CRPS (syndrome duration >1 year). Serial measurements of serum sIL-2R from early CRPS to persistent CRPS are needed to investigate whether serum sIL-2R levels can be used to monitor T-cell mediated inflammatory syndrome activity.

Keyphrases

case report
binding protein